As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Global restriction endonuclease market is expected to grow at a formidable CAGR during the forecast period. The key factor responsible for market growth is growing investment in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, rising incidences of chronic health disorders like diabetes, cancer among others is anticipated to bode well for the growth of restriction endonuclease market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025.

The global restriction endonuclease market is segmented based on type, application, end type, source, cleavage, end-user, region and company. Based on type, the market can be segmented into Type I, Type II, Type III and Type IV. Out of which, the Type II segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its lead during the forecast years as well. This growth can be accredited to its use in molecular biology applications that are carried on everyday such as gene cloning and DNA fragmentation and analysis. Also, because these enzymes cleave DNA at fixed positions, therefore small, well-defined fragments of DNA are produced which assist in characterization of genes and genomes, thereby anticipated to boost the growth of Type II restriction endonucleases segment over the coming years. Moreover, increasing investments in development activities by biotechnology companies is further aiding the segmental growth.

Major players operating in the global restriction endonuclease market include New England Biolabs, Thermo Fisher Scientific, Takara Bio, Sigma-Aldrich, Illumina, Agilent Technologies, Promega, Jena Biosciences, Genetix Biotech Asia Pvt. Ltd., Roche, Merck, Pfizer, Amgen, Vertex Pharmaceuticals, BioMarin Pharmaceutical, PerkinElmer, Abcam, Abbexa, Sisco Research Laboratories Pvt Ltd, Nippon Gene. The companies operating in restriction endonuclease market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as developing novel technologies in order to meet the requirements of users and to make the industry highly competitive.

Years considered for this report:

Historical Years: 2015-2018                                                                         

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyse and forecast the market size of global restriction endonuclease market.
  • To classify and forecast global restriction endonuclease market based on type, application, end type, source, cleavage, end-user, company and regional distribution.
  • To identify drivers and challenges for global restriction endonuclease market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global restriction endonuclease market.
  • To conduct pricing analysis for global restriction endonuclease market.
  • To identify and analyse the profile of leading players operating in global restriction endonuclease market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global restriction endonuclease market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Restriction endonuclease companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to restriction endonuclease  
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global restriction endonuclease market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:
    • Type I
    • Type II
    • Type III
    • Type IV
  • Market, By Application:
    • Genetic Engineering
    • DNA Mapping
    • Gene Sequencing
    • Others
  • Market, By End Type:
    • Sticky End
    • Blunt End
  • Market, By Source:
    • Bacteria
    • Archaea
  • Market, By Cleavage Specificity:
    • Isoschizomers
    • Neoschizomers
  • Market, By End-User:
    • Pharmaceutical and Biotechnology Companies
    • Academic Research Institutes
    • Others
  • Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India 
      • Japan
      • South Korea
      • Australia
      • Singapore
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global restriction endonuclease market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Restriction Endonuclease Market

4.    Executive Summary

5.    Global Restriction Endonuclease Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Type (I, II, III, IV)

5.2.2.     By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others)

5.2.3.     By End Type (Sticky End, Blunt End)

5.2.4.     By Source (Bacteria, Archaea)

5.2.5.     By Cleavage Specificity (Isoschizomers, Neoschizomers)

5.2.6.     By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others)

5.2.7.     By Company (2019)

5.2.8.     By Region

5.3.  Market Attractiveness Index

6.    Asia-Pacific Restriction Endonuclease Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Type

6.2.2.     By Application

6.2.3.     By End Type

6.2.4.     By Source

6.2.5.     By Cleavage Specificity

6.2.6.     By End-User

6.2.7.     By Country

6.3.  Market Attractiveness Index

6.4.  Asia-Pacific: Country Analysis

6.4.1.     China Restriction Endonuclease Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Type

6.4.1.2.2.             By Application

6.4.1.2.3.             By End Type

6.4.1.2.4.             By Source

6.4.1.2.5.             By Cleavage Specificity

6.4.1.2.6.             By End-User

6.4.2.     India Restriction Endonuclease Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Type

6.4.2.2.2.             By Application

6.4.2.2.3.             By End Type

6.4.2.2.4.             By Source

6.4.2.2.5.             By Cleavage Specificity

6.4.2.2.6.             By End-User

6.4.3.     Japan Restriction Endonuclease Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Type

6.4.3.2.2.             By Application

6.4.3.2.3.             By End Type

6.4.3.2.4.             By Source

6.4.3.2.5.             By Cleavage Specificity

6.4.3.2.6.             By End-User

6.4.4.     South Korea Restriction Endonuclease Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Type

6.4.4.2.2.             By Application

6.4.4.2.3.             By End Type

6.4.4.2.4.             By Source

6.4.4.2.5.             By Cleavage Specificity

6.4.4.2.6.             By End-User

6.4.5.     Singapore Restriction Endonuclease Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Type

6.4.5.2.2.             By Application

6.4.5.2.3.             By End Type

6.4.5.2.4.             By Source

6.4.5.2.5.             By Cleavage Specificity

6.4.5.2.6.             By End-User

6.4.6.     Australia Restriction Endonuclease Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Type

6.4.6.2.2.             By Application

6.4.6.2.3.             By End Type

6.4.6.2.4.             By Source

6.4.6.2.5.             By Cleavage Specificity

6.4.6.2.6.             By End-User

7.    Europe Restriction Endonuclease Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Application

7.2.3.     By End Type

7.2.4.     By Source

7.2.5.     By Cleavage Specificity

7.2.6.     By End-User

7.2.7.     By Country

7.3.  Market Attractiveness Index

7.4.  Europe: Country Analysis

7.4.1.     France Restriction Endonuclease Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Type

7.4.1.2.2.             By Application

7.4.1.2.3.             By End Type

7.4.1.2.4.             By Source

7.4.1.2.5.             By Cleavage Specificity

7.4.1.2.6.             By End-User

7.4.2.     Germany Restriction Endonuclease Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Type

7.4.2.2.2.             By Application

7.4.2.2.3.             By End Type

7.4.2.2.4.             By Source

7.4.2.2.5.             By Cleavage Specificity

7.4.2.2.6.             By End-User